Obesity is a risk factor in many diseases, such as hypertension, coronary artery disease, type II diabetes, breast and colon cancer, constituting a current pandemic disorder.

Ghrelin ([@b9-gmb-34-1-205]), a peptide related to food intake, is coded by the *GHRL* gene (3p25--p26). The GHS (growth hormone secretagogue) receptor is activated by acylated ghrelin, although not so with des-acyl ghrelin ([@b8-gmb-34-1-205]). In rodents, it was shown that the administration of ghrelin leads to a gain in weight by increasing food intake and reducing fat utilization ([@b14-gmb-34-1-205]). It was further proposed that the decrease in plasma ghrelin concentration found in obese individuals could represent a physiological adaptation ([@b15-gmb-34-1-205]).

Butyrylcholinesterase (BChE; EC 1.1.1.8) plasma activity is positively correlated with weight and BMI (body mass index), in a phenotype (CHE2 C5-) with approximately 90% population frequency ([@b3-gmb-34-1-205]; [@b2-gmb-34-1-205]), whereas in another (CHE2 C5+; 10% population frequency), with 20% higher BChE activity than the former, it is associated with lower mean weight ([@b3-gmb-34-1-205]) and lower mean BMI ([@b1-gmb-34-1-205]). This shows that individuals with innate high BChE activity tend to be thinner and that BChE synthesis is increased in individuals that gain weight, suggesting that BChE activity is important in energy balance. Data from the BChE knockout mouse that became obese and significantly heavier than wild-type littermates after an 11% fat diet indicate a role for BChE in fat utilization ([@b11-gmb-34-1-205]). Furthermore, SNPs of the human *BCHE* gene (3q26.1--q26.2) have been associated to BMI ([@b13-gmb-34-1-205]; [@b6-gmb-34-1-205]).

Considering that ghrelin desacylation may depend on BChE activity ([@b4-gmb-34-1-205]), the search was for relationships between SNPs of the *BCHE* and *GHRL* genes and the variables BChE activity, BMI and obesity.

The study involved 144 obese (BMI ≥ 30 kg/m^2^; mean age 36.6 years) and 153 control (20 kg/m^2^ ≤ BMI \< 25 kg/m^2^; mean age 36.3 years) male blood donors from Curitiba, south Brazil, ethnically characterized as Euro-Brazilians on the basis of skin, hair and facial traits. The research was approved by the National's Committee for Ethics in Research (CONEP; registration number 2063).

DNA was extracted by a salting-out method (Lahiri and Nurnberger Jr, 1991). SNPs were examined for the *GHRL* gene (G/A, rs34911341, *p.R51Q,* 346 nt and C/A, rs 696217, *p.L72M,* 408 nt) by PCR and Single Strand Conformation Analysis. The respective primers designed for this study were: GHRL15 (TCTCCCAGAGCACAAA GGAC); GHRL13 (TTCTGCTTGACCTCCATCTTCC); GHRL25 (GGAGTCGAAGAAGCCACCA); and GHRL23 (CAGAAGCATAAAACTGCAGAGG). Data on genotypes for exons 1 (G/A, rs1126680, −116 nt) and 4 (G/A; rs1803274, *p.A539T*; 1615 nt) of the *BCHE* gene, and BChE plasma activity ([@b5-gmb-34-1-205]) were obtained from a previous study ([@b6-gmb-34-1-205]).

Statistica for Windows (StatSoft, Inc., 1996) was used for data analysis of: means, frequencies, standard errors, standard deviations, Fisher-exact test, t-test, χ^2^ test, linear correlations, and step-wise multiple regression analysis.

Comparisons by χ^2^ tests showed that genotype and allele frequencies for *Arg51Gln* and *Leu72Met* SNPs of the *GHRL* gene did not statistically differ in obese (*51RR* = 99.3%, *51RQ* = 0.7%; *51Q* = 0.35%, and *72LL* = 88.1%, *72LM* = 11.2%, *72MM* = 0.3%; *72M* = 6.3% in 141 and 143 subjects, respectively) or control (*51RR* = 98.7%, *51RQ* = 1.3%; *51Q* = 0.65%, and *72LL* = 87.6%, *72LM* = 11.8%, *72MM* = 0.6%; *72M* = 6.5% in 153 subjects) individuals. [@b16-gmb-34-1-205] also did not find any significant difference in *51Q* allele frequency when comparing obese with normal individuals, but did show that there was a variation in samples of different ethnic composition. In a previous study, no significant difference was found in *72M* frequency between obese and non-obese individuals ([@b7-gmb-34-1-205]). Although total *72M* frequency (6.4%; N = 296) in the present study was no different from that obtained for individuals from Utah (8.3%; p \> 0.4), it differs significantly from those found for Han Chinese (15.6%, p \< 0.01), Japanese (18.2%; p \< 0.001), and African individuals (0.8%; p \< 0.05), all of which from the International HapMap Project, thereby showing an ethnic difference involved in the frequency of this variant.

Multiple regression step-wise analysis ([Table 1](#t1-gmb-34-1-205){ref-type="table"}) indicated two values for beta, both significantly different from 0, when compared by t-tests: the --*116A* variant leads to lower BChE activity whereas the *72M* to higher. Although BChE activity tends to be higher in obese than in non-obese individuals ([@b6-gmb-34-1-205]), the *72M* variant appears to contribute to elevating this even more. This significant association is a novelty, and may be considered an inference, as significance comes close to the 0.05 error limit. This may be due to a regulatory mechanism by which the presence of the *72M* variant of the *GHRL* gene induces BChE synthesis. The --*116GG* genotype is characterized by normal BChE activity. However, in the presence of the *72M* variant, mean BChE activity is higher (t = 2.18, p \< 0.05) ([Table 2](#t2-gmb-34-1-205){ref-type="table"}). High BChE activity (\> 8 KU/L) was shown in 33% of obese subjects with the *72M* variant, but in only 21% of those homozygous for the *72L* SNP. Although the *L72M* SNP is not located in the coding region for the mature ghrelin peptide, the *72M* allele leads to an earlier onset of obesity ([@b17-gmb-34-1-205]; [@b12-gmb-34-1-205]). According to [@b16-gmb-34-1-205], variation in preproghrelin peptide could theoretically change the structure of one or more of the derived products, this leading to functional consequences.

The association between the --*116A* variant and lower BChE activity ([Table 1](#t1-gmb-34-1-205){ref-type="table"}) is already known, and has been reported in obese and nonobese individuals ([@b6-gmb-34-1-205]).

Genotypes *72LL* and *72LM*+*72MM* did not differ significantly (t-test) in mean BMI in either control (23.05 ± 1.29 kg/m^2^ and 23.43 ± 0.96 kg/m^2^; p \> 0.20) or obese (32.95 ± 3.29 kg/m^2^ and 32.90 ± 2.7 kg/m^2^; p \> 0.95) individuals. No difference in mean BMI was found in obese individuals, when genotypes *72LL* and *72LM*+*72MM,* identical for genotypes --*116GG;539AA*, --*116GG;539AT* or --*116GA;539AT* of exons 1 and 4 of the *BCHE* gene, respectively, were compared. Obese individuals with and without the *72M* variant have already been compared ([@b17-gmb-34-1-205]), with no difference found in mean BMI.

Although the examined *GHRL* SNPs do not appear to be directly related to BMI, the association of the *72M* SNP with higher BChE activity in obese subjects although requiring further study, points to a regulatory mechanism, thus indicating the influence of the *GHRL* gene on BChE expression and, consequently, its possible role in the complex process of fat utilization.
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###### 

Results from step-wise multiple regression analysis that considered butyrylcholinesterase activity as dependent variable in obese individuals (N = 130).

  Independent variables[^a^](#tfn1-gmb-34-1-205){ref-type="table-fn"}   Beta[^b^](#tfn2-gmb-34-1-205){ref-type="table-fn"} ± S.E.   t
  --------------------------------------------------------------------- ----------------------------------------------------------- ------------------
  *BCHE* gene[^c^](#tfn3-gmb-34-1-205){ref-type="table-fn"}             --0.21 ± 0.09                                               2.51 (p \< 0.02)
  *GHRL* gene[^d^](#tfn4-gmb-34-1-205){ref-type="table-fn"}             0.18 ± 0.09                                                 2.09 (p \< 0.05)
                                                                                                                                    
                                                                        F = 5.52 (p \< 0.01); r^2^ = 0.08                           

Nonsignificant independent variables: age, body-mass index, *A539T* of the *BCHE* gene.

Regression coefficients for the standardized variables to a mean 0 and SD 1, allowing for comparison of the relative contribution of each independent variable in predicting the dependent variable, also comparable across variables.

(--*116GG* = 1, --*116GA* = 2).

(*72LL* = 1, *72LM*+*72MM* = 2).

###### 

Butyrylcholinesterase mean activity in 130 obese individuals, grouped by genotypes of *GHRL* (*Leu72Met*) and *BCHE* (*G-116A*) genes.

  Genotypes                                                                n    Mean BChE activity (KU/L) ± S.D.
  ------------------------------------------------------------------------ ---- ----------------------------------
  *72LM+72MM*; --*116GG*[*^a^*](#tfn5-gmb-34-1-205){ref-type="table-fn"}   13   8.42 ± 4.08
  *72LL*; --*116GG*[*^a^*](#tfn5-gmb-34-1-205){ref-type="table-fn"}        95   6.55 ± 2.80
  *72LM+72MM*; --*116GA*                                                   2    5.22 ± 1.89
  *72LL*; --*116GA*                                                        20   5.04 ± 2.11

t-test = 2.18; p \< 0.05 when comparing *72LM+72MM; −116GG* with *72LL; −116GG*.
